Clinical Trial

Vascular Infections Caused by Coxiella Burnetii

Study acronym: COXIVAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
high morbidity and mortality. In France, Coxiella burnetii-related vascular infections appear to be increasing, though data remain limited. Two-year mortality reaches 15-18%, mainly due to serious complications such as arterio-digestive fistulas. Diagnosis is often delayed, prognostic factors are poorly defined, and the value of advanced imaging techniques remains insufficiently studied.
Trial Details
NCT Number NCT07305402
Lead Sponsor University Hospital, Bordeaux
Conditions Vascular Infection Caused by C. Burnetii
Enrollment 400 participants
Start Date 2026-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-12-26